# NCT02897479 (NCT02897479)

> A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02897479
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Hutchison Medipharma Limited
- Conditions: Lung Sarcomatoid Carcinoma
- Interventions: Savolitinib
- Enrollment: 76
- Primary outcome: To assess objective response rate (ORR)

## Indexed commentary on NCT02897479 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct02897479